# Retatrutide TRANSCEND Phase 3: What the Data Actually Shows The TRANSCEND Phase 3 trial results for retatrutide are now published, and the numbers are significant enough to shift how clinicians and patients approach GLP-1 class therapy
Some mild side effects and interactions have been noted, but for the most part, no, they arent any major dangers to taking NAD supplements
Until now, the cause of PD is unknown, but several factors seem to play a role, including environmental factors, such as the pesticide rotenone, that can block mitochondrial functions
Can you lose weight on the starting dose of retatrutide
The FDA says it lacks sufficient information to know whether the drug would cause harm when administered to humans. Both Dr
The entire staff were also so nice